Acknowledgement to Referees.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 4, p. 151, doi. 10.1007/s40801-019-00170-x
- Publication type:
- Article
Works matching IS 21989788 AND DT 2019 AND VI 6 AND IP 4
Results: 7
1
2
RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 4, p. 193, doi. 10.1007/s40801-019-00167-6
- By:
- Publication type:
- Article
3
A Retrospective Observational Study to Determine Baseline Characteristics and Early Prescribing Patterns for Patients Receiving Alirocumab in UK Clinical Practice.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 4, p. 205, doi. 10.1007/s40801-019-00166-7
- By:
- Publication type:
- Article
4
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™).
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 4, p. 183, doi. 10.1007/s40801-019-00165-8
- By:
- Publication type:
- Article
5
Comparison of Two Corticosteroid Pre-Infusion Regimens for Pegloticase in the United States: A Retrospective Analysis in Community Rheumatology Practices.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 4, p. 165, doi. 10.1007/s40801-019-00164-9
- By:
- Publication type:
- Article
6
Trends of Opioid Utilisation in Denmark: A Nationwide Study.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 4, p. 155, doi. 10.1007/s40801-019-00163-w
- By:
- Publication type:
- Article
7
Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 4, p. 173, doi. 10.1007/s40801-019-00162-x
- By:
- Publication type:
- Article